Development of 3D Human Blood Brain Barrier Formation Assay

1 (a) (2)(ii) which states� Only one responsible source and no other supplies or services will satisfy agency requirement�. The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price Purchase Order. MINIMUM REQUIREMENTS: See

Attached Statement of Work This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrat